ISRCTN05886349已完成未知
The STARS (STeroids Against Re-Stenosis) trial: the use of peri-procedural oral corticosteriods to prevent in-segment re-stenosis after percutaneous coronary intervention
South Tees Hospitals NHS Trust (UK)0 个研究点目标入组 548 人开始时间: 2007年8月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 548
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Any patient awaiting percutaneous coronary intervention for symptomatic coronary artery disease (elective or acute)
- •2. Documented myocardial ischaemia
- •3. Coronary angiography demonstrating at least a 50% reduction of the luminal diameter in at least one native coronary artery (as measured by quantitative computerised angiography)
- •4. Any lesion more than 3 mm diameter
排除标准
- •1. Proposed use of a drug eluting stent (in the study vessel[s])
- •2. Left Main Stem stenosis
- •3. Primary Percutaneous Coronary Intervention (PCI) for ST elevation myocardial infarction
- •4. Steroid therapy within 30-days of study enrolment
- •5. Contraindication to corticosteroid use
- •6. Previous inclusion in this study
- •7. Non-cardiac disease likely to cause death within six months
- •8. Inter-hospital transfers from Cumbria
研究者
相似试验
进行中（未招募）
1 期
The STARS (STeroids Against Re-Stenosis) Trial[THE USE OF Peri-PROCEDURAL ORAL CORTICOSTERIODS TO PREVENT IN-SEGMENT RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION.] - The STARS TrialEUCTR2004-002304-16-GBSouth Tees Hospitals NHS Foundation Trust548
进行中（未招募）
2 期
Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney, a Phase II Clinical Trial (FASTRACK II)Renal cell carcinoma with a single lesion within a kidneyPrimary kidney tumour intact and no more than 5 documented metastasesCancer - KidneyACTRN12615001181594Trans Tasman Radiation Oncology Group (TROG)71
已完成
不适用
Observational cohort of patients treated with stereotactic radiotherapy for Oligo LYMPh nOde and other soft tissue metastasiSmetastasessoft tissue oligometastases10027476NL-OMON48987niversitair Medisch Centrum Utrecht700
进行中（未招募）
不适用
STAR: A Randomised Multi-Stage Phase II/III trial of Sunitinib comparing Temporary cessation with Allowing continuation, at the time of maximal radiological response, in the first-line treatment of locally advanced and/or metastatic Renal cancer - STAR-Standard vs Modified Sunitinib Treatment in Renal Cancer V1.0Metastatic and/or locally advanced Renal Clear Cell CarcinomaEUCTR2011-001098-16-GBniversity of Leeds1,000
已完成
不适用
A randomised controlled trial of intravenous steroids at home versus outpatients department for treatment of acute multiple sclerosis relapseservous System Diseases: Multiple sclerosis (MS)Nervous System DiseasesISRCTN95588376Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)164